Global Thalassemia Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Thalassemia Revenue
• 1.4 Market by Type
  • 1.4.1 Global Thalassemia Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Iron Chelating Drugs
  • 1.4.3 Others
• 1.5 Market by Application
  • 1.5.1 Global Thalassemia Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Research Institute
  • 1.5.5 Laboratories
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Thalassemia Market Perspective (2015-2026)
• 2.2 Global Thalassemia Growth Trends by Regions
  • 2.2.1 Thalassemia Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Thalassemia Historic Market Share by Regions (2015-2020)
  • 2.2.3 Thalassemia Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Thalassemia Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Thalassemia Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Thalassemia Players by Market Size
  • 3.1.1 Global Top Thalassemia Players by Revenue (2015-2020)
  • 3.1.2 Global Thalassemia Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Thalassemia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Thalassemia Market Concentration Ratio
  • 3.2.1 Global Thalassemia Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Thalassemia Revenue in 2019
• 3.3 Thalassemia Key Players Head office and Area Served
• 3.4 Key Players Thalassemia Product Solution and Service
• 3.5 Date of Enter into Thalassemia Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Thalassemia Historic Market Size by Type (2015-2020)
• 4.2 Global Thalassemia Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Thalassemia Market Size by Application (2015-2020)
• 5.2 Global Thalassemia Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Thalassemia Market Size (2015-2020)
• 6.2 Thalassemia Key Players in North America (2019-2020)
• 6.3 North America Thalassemia Market Size by Type (2015-2020)
• 6.4 North America Thalassemia Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Thalassemia Market Size (2015-2020)
• 7.2 Thalassemia Key Players in Europe (2019-2020)
• 7.3 Europe Thalassemia Market Size by Type (2015-2020)
• 7.4 Europe Thalassemia Market Size by Application (2015-2020)

8 China

• 8.1 China Thalassemia Market Size (2015-2020)
• 8.2 Thalassemia Key Players in China (2019-2020)
• 8.3 China Thalassemia Market Size by Type (2015-2020)
• 8.4 China Thalassemia Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Thalassemia Market Size (2015-2020)
• 9.2 Thalassemia Key Players in Japan (2019-2020)
• 9.3 Japan Thalassemia Market Size by Type (2015-2020)
• 9.4 Japan Thalassemia Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Thalassemia Market Size (2015-2020)
• 10.2 Thalassemia Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Thalassemia Market Size by Type (2015-2020)
• 10.4 Southeast Asia Thalassemia Market Size by Application (2015-2020)

11 India

• 11.1 India Thalassemia Market Size (2015-2020)
• 11.2 Thalassemia Key Players in India (2019-2020)
• 11.3 India Thalassemia Market Size by Type (2015-2020)
• 11.4 India Thalassemia Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Thalassemia Market Size (2015-2020)
• 12.2 Thalassemia Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Thalassemia Market Size by Type (2015-2020)
• 12.4 Central & South America Thalassemia Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Bluebird bio, Inc.
  • 13.1.1 Bluebird bio, Inc. Company Details
  • 13.1.2 Bluebird bio, Inc. Business Overview
  • 13.1.3 Bluebird bio, Inc. Thalassemia Introduction
  • 13.1.4 Bluebird bio, Inc. Revenue in Thalassemia Business (2015-2020))
  • 13.1.5 Bluebird bio, Inc. Recent Development
• 13.2 Acceleron Pharma, Inc.
  • 13.2.1 Acceleron Pharma, Inc. Company Details
  • 13.2.2 Acceleron Pharma, Inc. Business Overview
  • 13.2.3 Acceleron Pharma, Inc. Thalassemia Introduction
  • 13.2.4 Acceleron Pharma, Inc. Revenue in Thalassemia Business (2015-2020)
  • 13.2.5 Acceleron Pharma, Inc. Recent Development
• 13.3 Celgene Corporation
  • 13.3.1 Celgene Corporation Company Details
  • 13.3.2 Celgene Corporation Business Overview
  • 13.3.3 Celgene Corporation Thalassemia Introduction
  • 13.3.4 Celgene Corporation Revenue in Thalassemia Business (2015-2020)
  • 13.3.5 Celgene Corporation Recent Development
• 13.4 GlaxoSmithKline plc
  • 13.4.1 GlaxoSmithKline plc Company Details
  • 13.4.2 GlaxoSmithKline plc Business Overview
  • 13.4.3 GlaxoSmithKline plc Thalassemia Introduction
  • 13.4.4 GlaxoSmithKline plc Revenue in Thalassemia Business (2015-2020)
  • 13.4.5 GlaxoSmithKline plc Recent Development
• 13.5 Incyte Corporation
  • 13.5.1 Incyte Corporation Company Details
  • 13.5.2 Incyte Corporation Business Overview
  • 13.5.3 Incyte Corporation Thalassemia Introduction
  • 13.5.4 Incyte Corporation Revenue in Thalassemia Business (2015-2020)
  • 13.5.5 Incyte Corporation Recent Development
• 13.6 Gamida Cell
  • 13.6.1 Gamida Cell Company Details
  • 13.6.2 Gamida Cell Business Overview
  • 13.6.3 Gamida Cell Thalassemia Introduction
  • 13.6.4 Gamida Cell Revenue in Thalassemia Business (2015-2020)
  • 13.6.5 Gamida Cell Recent Development
• 13.7 Kiadis Pharma
  • 13.7.1 Kiadis Pharma Company Details
  • 13.7.2 Kiadis Pharma Business Overview
  • 13.7.3 Kiadis Pharma Thalassemia Introduction
  • 13.7.4 Kiadis Pharma Revenue in Thalassemia Business (2015-2020)
  • 13.7.5 Kiadis Pharma Recent Development
• 13.8 La Jolla Pharmaceutical Company
  • 13.8.1 La Jolla Pharmaceutical Company Company Details
  • 13.8.2 La Jolla Pharmaceutical Company Business Overview
  • 13.8.3 La Jolla Pharmaceutical Company Thalassemia Introduction
  • 13.8.4 La Jolla Pharmaceutical Company Revenue in Thalassemia Business (2015-2020)
  • 13.8.5 La Jolla Pharmaceutical Company Recent Development
• 13.9 IONIS Pharmaceuticals
  • 13.9.1 IONIS Pharmaceuticals Company Details
  • 13.9.2 IONIS Pharmaceuticals Business Overview
  • 13.9.3 IONIS Pharmaceuticals Thalassemia Introduction
  • 13.9.4 IONIS Pharmaceuticals Revenue in Thalassemia Business (2015-2020)
  • 13.9.5 IONIS Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer